The DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Meropenem dosing in critically ill patients with sepsis and without renal dysfunction: intermittent bolus versus continuous administration? Monte Carlo dosing simulations and subcutaneous tissue distribution
Abstract
OBJECTIVES: To compare the plasma and subcutaneous tissue concentration-time profiles of meropenem administered by intermittent bolus dosing or continuous infusion to critically ill patients with sepsis and without renal dysfunction, and to use population pharmacokinetic modelling and Monte Carlo simulations to assess the cumulative fraction of response (CFR) against Gram-negative pathogens likely to be encountered in critical care units. PATIENTS AND METHODS: We randomized 10 patients with sepsis to receive meropenem by intermittent bolus administration (n = 5; 1 g 8 hourly) or an equal dose administered by continuous infusion (n = 5). Serial subcutaneous tissue concentrations were determined using microdialysis and compared with plasma data for first-dose and steady-state pharmacokinetics. Population pharmacokinetic modelling of plasma data and Monte Carlo simulations were then undertaken with NONMEM. RESULTS: It was found that continuous infusion maintains higher median trough concentrations, in both plasma (intermittent bolus 0 versus infusion 7 mg/L) and subcutaneous tissue (0 versus 4 mg/L). All simulated intermittent bolus, extended and continuous infusion dosing achieved 100% of pharmacodynamic targets against most Gram-negative pathogens. Superior obtainment of pharmacodynamic targets was achieved using administration by extended or continuous infusion against less susceptible Pseudomonas aeruginosa and Acinetobacter species. CONCLUSIONS: This is the first study to compare the relative concentration-time data of bolus and continuous administration of meropenem at the subcutaneous tissue and plasma levels. We found that the administration of meropenem by continuous infusion maintains higher concentrations in subcutaneous tissue and plasma than by intermittent bolus dosing. Administration by extended or continuous infusion will achieve superior CFR against less-susceptible organisms in patients without renal dysfunction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prediction of Creatinine Clearance from Serum Creatinine
Cockcroft, D. W., & Gault, H. (1976) · Nephron · doi:10.1159/000180580 · Cited by 15,309
Bone, R. C., Balk, R. A., Cerra, F. B., Dellinger, R. P., Fein, A. M., Knaus, W. A., Schein, R. M. H., & Sibbald, W. J. (1992) · Chest · doi:10.1378/chest.101.6.1644 · Cited by 13,198
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109
Inadequate Antimicrobial Treatment of Infections
Kollef, M. H., Sherman, G., Ward, S., & Fraser, V. J. (1999) · Chest · doi:10.1378/chest.115.2.462 · Cited by 1,805
Antimicrobial pharmacodynamics: critical interactions of 'bug and drug'
Drusano, G. L. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro862 · Cited by 930
Garnacho-Montero, J., Garcia-Garmendia, J. L., Barrero-Almodovar, A., Jimenez-Jimenez, F. J., Perez-Paredes, C., & Ortiz-Leyba, C. (2003) · Critical Care Medicine · doi:10.1097/01.ccm.0000098031.24329.10 · Cited by 718
Mouton, J. W., Dudley, M. N., Cars, O., Derendorf, H., & Drusano, G. L. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki079 · Cited by 549
McKinnon, P. S., Paladino, J. A., & Schentag, J. J. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.12.009 · Cited by 464
Parke, J., Holford, N. H. G., & Charles, B. G. (1999) · Computer Methods and Programs in Biomedicine · doi:10.1016/s0169-2607(98)00098-4 · Cited by 350
Tissue concentrations: do we ever learn?
Mouton, J. W., Theuretzbacher, U., Craig, W. A., Tulkens, P. M., Derendorf, H., & Cars, O. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm476 · Cited by 348
Clinical Pharmacodynamics of Meropenem in Patients with Lower Respiratory Tract Infections
Li, C., Du, X., Kuti, J. L., & Nicolau, D. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00294-06 · Cited by 289
Roberts, J. A., & Lipman, J. (2006) · Clinical Pharmacokinetics · doi:10.2165/00003088-200645080-00001 · Cited by 283
Self-citationJoukhadar, C., Frossard, M., Mayer, B. X., Brunner, M., Klein, N., Siostrzonek, P., Eichler, H. G., & Müller, M. (2001) · Critical Care Medicine · doi:10.1097/00003246-200102000-00030 · Cited by 279
Methodological issues in microdialysis sampling for pharmacokinetic studies
de Lange, E. C. M., de Boer, A. G., & Breimer, D. D. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00107-1 · Cited by 264
Roberts, J. A., Roberts, M. S., Robertson, T. A., Dalley, A. J., & Lipman, J. (2009) · Critical Care Medicine · doi:10.1097/ccm.0b013e3181968e44 · Cited by 183
Self-citationWang, Y., Wong, S. L., & Sawchuk, R. J. (1993) · Pharmaceutical Research · doi:10.1023/a:1018906821725 · Cited by 177
Microdialysis in peripheral tissues
de la Peña, A., Liu, P., & Derendorf, H. (2000) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(00)00106-x · Cited by 155
Continuous infusion of β-lactam antibiotics in severe infections: a review of its role
Roberts, J. A., Paratz, J., Paratz, E., Krueger, W. A., & Lipman, J. (2007) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2007.02.002 · Cited by 150
Self-citationAminoglycoside Volume of Distribution and Illness Severity in Critically Ill Septic Patients
Marik, P. E. (1993) · Anaesthesia and Intensive Care · doi:10.1177/0310057x9302100206 · Cited by 145
Lau, W. K. K., Mercer, D., Itani, K. M. F., Nicolau, D. P., Kuti, J. L., Mansfield, D. L., & Dana, A. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00329-06 · Cited by 139
Ryan, D. M. (1993) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/31.suppl_d.1 · Cited by 133
Continuous infusion versus intermittent administration of meropenem in critically ill patients
Thalhammer, F., Traunmüller, F., Menyawi, I. E., Frass, M., Hollenstein, U., Locker, G. J., Stoiser, B., Staudinger, T., Thalhammer-Scherrer, R., & Burgmann, H. (1999) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/43.4.523 · Cited by 125
Buijk, S. L. C. E., Gyssens, I. C., Mouton, J. W., Vliet, A. V., Verbrugh, H. A., & Bruining, H. A. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.1.121 · Cited by 119
Matthews, I., Kirkpatrick, C. M. J., & Holford, N. H. G. (2004) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.2004.02114.x · Cited by 110
Self-citationKrueger, W. A., Bulitta, J. B., Kinzig‐Schippers, M., Landersdorfer, C. B., Holzgrabe, U., Naber, K. G., Drusano, G. L., & Sörgel, F. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.5.1881-1889.2005 · Cited by 105
Pharmacokinetics and pharmacodynamics of meropenem in critically ill patients
Kitzes‐Cohen, R., Farin, D., Piva, G., & Myttenaere-Bursztein, S. A. D. (2002) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00474-5 · Cited by 97
Pharmacokinetic Evaluation of Meropenem and Imipenem in Critically Ill Patients with Sepsis
Novelli, A., Adembri, C., Livi, P., Fallani, S., Mazzei, T., & Gaudio, A. R. D. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544050-00007 · Cited by 93
Rhomberg, P. R., & Jones, R. N. (2006) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2006.07.009 · Cited by 53
Cited by
Tamma, P. D., Heil, E. L., Justo, J. A., Mathers, A. J., Satlin, M. J., & Bonomo, R. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae403 · Cited by 1,191
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad428 · Cited by 740
Tamma, P. D., Aitken, S. L., Bonomo, R. A., Mathers, A. J., van Duin, D., & Clancy, C. J. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac268 · Cited by 526
Treatment Options for Carbapenem-Resistant Enterobacteriaceae Infections
Morrill, H. J., Pogue, J. M., Kaye, K. S., & LaPlante, K. L. (2015) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofv050 · Cited by 435
Antibiotics in critically ill patients: A systematic review of the pharmacokinetics of β-lactams.
Gonçalves-Pereira, J., & Póvoa, P. (2011) · Critical Care · doi:10.1186/cc10441 · Cited by 408
Metadata
- Authors
- Roberts, J. A., Kirkpatrick, C. M. J., Roberts, M. S., Robertson, T. A., Dalley, A. J., & Lipman, J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-04-27
- Volume
- 64
- Issue
- 1
- Pages
- 142-150
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2135190942
- Cited by
- 347
- References
- 28
- FWCI
- 15.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.